You are here

SUBSCRIBERS

How Singapore can lead biopharma innovation

The Republic needs to align its patent term extension regime with international standards, and so start attracting more clinical trials.

BT_20200304_AJPHARM_4050758.jpg
For pharmaceutical companies, patents are the primary way to offset the high R&D costs that can stretch over decades, and ensure sustainable investment into the medicines of tomorrow.

SINGAPORE is known by the global innovation and intellectual property (IP) expert community as a leader in the protection of IP rights. The latest International Property Rights Index for 2019 again listed Singapore as having Asia's strongest protection of intellectual property (IP) rights;...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes